Wanda Castro-Borrero

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Cross Sectional

Replacement Therapy

Multiple Sclerosis

Top Venues

Multiple sclerosis journal - experimental, translational and clinical

Multiple sclerosis (Houndmills, Basingstoke, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Marco Salvetti, Sibyl Wray, Gereon Nelles, Nicholas Belviso, Achint Kumar, Thijs Koster, Wanda Castro-Borrero, Megan Vignos, null null
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program. Multiple sclerosis journal - experimental, translational and clinical 10 (2) (2024)
Marco Salvetti, Sibyl Wray, Gereon Nelles, Nicholas Belviso, Achint Kumar, Thijs Koster, Wanda Castro-Borrero, Megan Vignos, null null
Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program. Multiple sclerosis journal - experimental, translational and clinical 10 (2) (2024)
Xiaotong Jiang, Gabrielle Simoneau, Mel Zuercher, Yanic Heer, Philip van Hoevell, Adrian Harrington, Wanda Castro-Borrero, Carl de Moor, Fabio Pellegrini, Lu Tian, Arnfin Bergmann, Stefan Braune
Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: A novel approach to precision medicine applied to the German NeuroTrans Data Multiple Sclerosis Registry. Multiple sclerosis journal - experimental, translational and clinical 9 (3) (2023)
Barry A Singer, Douglas Lorne Arnold, Jelena S Drulovic, Mark S Freedman, Ralf Gold, Mark Gudesblatt, Elżbieta Jasińska, Christopher C LaGanke, Robert T Naismith, Donald Negroski, Jiwon Oh, Miguel Angel Hernandez Perez, Krzysztof Selmaj, Florian Then Bergh, Annette Wundes, Tjalf Ziemssen, Wanda Castro-Borrero, Hailu Chen, Seth Levin, Matthew Scaramozza, Sai L Shankar, Ting Wang, Sibyl Wray
Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study. Multiple sclerosis (Houndmills, Basingstoke, England) (2023)